{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T06:13:36Z","timestamp":1768457616557,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Complementary Therapies in Medicine"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.ctim.2018.03.007","type":"journal-article","created":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T15:02:41Z","timestamp":1521126161000},"page":"167-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Red Yeast Rice (RYR) supplementation in patients treated with second-generation antipsychotics"],"prefix":"10.1016","volume":"37","author":[{"given":"Antonio","family":"Bruno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluca","family":"Pandolfo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Crucitti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia Maria","family":"Troili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edoardo","family":"Spina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocco Antonio","family":"Zoccali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7271-6989","authenticated-orcid":false,"given":"Maria Rosaria Anna","family":"Muscatello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctim.2018.03.007_bib0005","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/j.2051-5545.2011.tb00014.x","article-title":"Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care","volume":"10","author":"De Hert","year":"2011","journal-title":"World Psychiatry"},{"issue":"10","key":"10.1016\/j.ctim.2018.03.007_bib0010","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1080\/14740338.2016.1201475","article-title":"An update of safety of clinically used atypical antipsychotics","volume":"15","author":"Orsolini","year":"2016","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.ctim.2018.03.007_bib0015","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1471-244X-11-118","article-title":"Is antipsychotic polypharmacy associated with metabolic syndrome even after adjustment for lifestyle effects? A cross-sectional study","volume":"11","author":"Misawa","year":"2011","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.ctim.2018.03.007_bib0020","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pnpbp.2016.06.012","article-title":"Dysregulation of hypothalamic modulation in olanzapine treated male rats","volume":"71","author":"Sezlev-Bilecen","year":"2016","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.ctim.2018.03.007_bib0025","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/sj.npp.1300027","article-title":"H1-histamine receptor affinity predicts short term weight gain for typical and atypical antipsychotic drugs","volume":"28","author":"Kroeze","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.ctim.2018.03.007_bib0030","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00213-011-2397-y","article-title":"Acute effects of orexigenic antipsychotic drugs on lipid and carbohydrate metabolism in rat","volume":"219","author":"Jassim","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.ctim.2018.03.007_bib0035","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.phrs.2007.05.007","article-title":"Olanzapine induces SREBP-1-relatedadipogenesis in 3T3-L1 cells","volume":"56","author":"Yang","year":"2007","journal-title":"Pharmacol Res"},{"issue":"3","key":"10.1016\/j.ctim.2018.03.007_bib0040","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/YIC.0000000000000014","article-title":"Pharmacological treatment of antipsychotic-induced dyslipidemia and hypertension","volume":"29","author":"Tse","year":"2014","journal-title":"Int Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.ctim.2018.03.007_bib0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/0269881107077815","article-title":"Statins are effective in treating dyslipidemia among psychiatric patients using second-generation antipsychotic agents","volume":"22","author":"Ojala","year":"2008","journal-title":"J Psychopharmacol"},{"issue":"1","key":"10.1016\/j.ctim.2018.03.007_bib0050","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ijc.24813","article-title":"Cytotoxic effects of antipsychotic drugs implicate cholesterol homeostasis as a novel chemotherapeutic target","volume":"126","author":"Wiklund","year":"2010","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.ctim.2018.03.007_bib0055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11274-016-2035-2","article-title":"Functional food Red Yeast Rice (RYR) for metabolic syndrome amelioration: a review on pros and cons","volume":"32","author":"Patel","year":"2016","journal-title":"World J Microbiol Biotechnol"},{"issue":"6","key":"10.1016\/j.ctim.2018.03.007_bib0060","doi-asserted-by":"crossref","first-page":"e98611","DOI":"10.1371\/journal.pone.0098611","article-title":"A meta-analysis of red yeast rice: an effective and relatively safe alternative approach for dyslipidemia","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ctim.2018.03.007_bib0065","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1749-8546-1-4","article-title":"Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials","volume":"1","author":"Liu","year":"2006","journal-title":"Chin Med"},{"issue":"11","key":"10.1016\/j.ctim.2018.03.007_bib0070","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1021\/jf000338c","article-title":"Constituents of red yeast rice, a traditional Chinese food and medicine","volume":"48","author":"Ma","year":"2000","journal-title":"J Agric Food Chem"},{"issue":"8","key":"10.1016\/j.ctim.2018.03.007_bib0075","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.nutres.2013.05.015","article-title":"Red yeast rice improves lipid pattern, high-sensitivity C-reactive protein, and vascular remodeling parameters in moderately hypercholesterolemic Italian subjects","volume":"33","author":"Cicero","year":"2013","journal-title":"Nutr Res"},{"issue":"4","key":"10.1016\/j.ctim.2018.03.007_bib0080","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/14017431003624123","article-title":"HypoCol (red yeast rice) lowers plasma cholesterol \u2013 a randomized placebo controlled study","volume":"44","author":"Bogsrud","year":"2010","journal-title":"Scand Cardiovasc J"},{"issue":"12","key":"10.1016\/j.ctim.2018.03.007_bib0085","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.amjcard.2008.02.056","article-title":"Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction","volume":"101","author":"Lu","year":"2008","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.ctim.2018.03.007_bib0090","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/HJR.0b013e32801da137","article-title":"Efficacy of Monascus purpureus Went rice on lowering lipid ratios in hypercholesterolemic patients","volume":"14","author":"Huang","year":"2007","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.ctim.2018.03.007_bib0095","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1530\/eje.1.02012","article-title":"Efficacy and safety of Monascus Purpureus went rice in subjects with hyperlipidemia","volume":"5","author":"Lin","year":"2005","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.ctim.2018.03.007_bib0100","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/ajcn\/69.2.231","article-title":"Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement","volume":"69","author":"Heber","year":"1999","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1016\/j.ctim.2018.03.007_bib0105","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.atherosclerosis.2015.04.004","article-title":"Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain \u2013 a systematic review and meta-analysis","volume":"240","author":"Gerards","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ctim.2018.03.007_bib0110","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.ctim.2018.03.007_bib0115","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol Rep"},{"key":"10.1016\/j.ctim.2018.03.007_bib0120","first-page":"151","article-title":"2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult","volume":"29","author":"Anderson","year":"2013","journal-title":"Can J Cardiol"},{"issue":"63","key":"10.1016\/j.ctim.2018.03.007_bib0125","first-page":"2889","article-title":"ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American college of cardiology\/american heart association task force on practice guidelines","volume":"2014","author":"Stone","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ctim.2018.03.007_bib0130","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1017\/S204579601500027X","article-title":"The epidemiology of common mental disorders from age 20\u201350: results from the prospective Zurich cohort study","volume":"25","author":"Angst","year":"2016","journal-title":"Epidemiol Psychiatr Sci"},{"key":"10.1016\/j.ctim.2018.03.007_bib0135","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.phrs.2015.07.022","article-title":"Metabolic syndrome and obesity among users of second generation antipsychotics: a global challenge for modern psychopharmacology","volume":"101","author":"Rojo","year":"2015","journal-title":"Pharmacol Res"},{"issue":"4","key":"10.1016\/j.ctim.2018.03.007_bib0140","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/0269881114562090","article-title":"First do no harm. A systematic review of the prevalence and management of antipsychotic adverse effects","volume":"29","author":"Young","year":"2015","journal-title":"J Psychopharmacol"},{"issue":"3","key":"10.1016\/j.ctim.2018.03.007_bib0145","first-page":"168","article-title":"Lifetime prevalence and age-of-onset distributions of mental disorders in the world health organization\u2019s world mental health survey initiative","volume":"6","author":"Kessler","year":"2007","journal-title":"World Psychiatry"},{"issue":"4","key":"10.1016\/j.ctim.2018.03.007_bib0150","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.bbrc.2014.07.005","article-title":"Atypical antipsychotics induce both proinflammatory and adipogenic gene expression in human adipocytes in vitro","volume":"450","author":"S\u00e1rv\u00e1ri","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"10.1016\/j.ctim.2018.03.007_bib0155","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.tem.2014.07.004","article-title":"Molecular pathophysiology of metabolic effects of antipsychotic medications","volume":"25","author":"Ballon","year":"2014","journal-title":"Trends Endocrinol Metab"}],"container-title":["Complementary Therapies in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229918301572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229918301572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:08:24Z","timestamp":1760807304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0965229918301572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":31,"alternative-id":["S0965229918301572"],"URL":"https:\/\/doi.org\/10.1016\/j.ctim.2018.03.007","relation":{},"ISSN":["0965-2299"],"issn-type":[{"value":"0965-2299","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Red Yeast Rice (RYR) supplementation in patients treated with second-generation antipsychotics","name":"articletitle","label":"Article Title"},{"value":"Complementary Therapies in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctim.2018.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}